Molecular Pharmacology: 48 (4)

October 01, 1995; Volume 48,Issue 4

You have access
Localization of P2X purinoceptor transcripts in the rat nervous system.
E J Kidd, C B Grahames, J Simon, A D Michel, E A Barnard and P P Humphrey

Molecular Pharmacology October 1995, 48 (4) 569-573;
You have access
A discrete site for general anesthetics on a postsynaptic receptor.
S A Forman, K W Miller and G Yellen

Molecular Pharmacology October 1995, 48 (4) 574-581;
You have access
Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
I Leduc, P Haddad, E Giasson and S Meloche

Molecular Pharmacology October 1995, 48 (4) 582-592;
You have access
Phosphorylation of cyclic AMP response element-binding protein and induction of c-fos gene expression on withdrawal from chronic treatment with carbachol in NG108-15 cells.
J M Thomas, J S Frazier, Z W Hu and B B Hoffman

Molecular Pharmacology October 1995, 48 (4) 593-600;
You have access
Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
B Lassègue, R W Alexander, G Nickenig, M Clark, T J Murphy and K K Griendling

Molecular Pharmacology October 1995, 48 (4) 601-609;
You have access
Differential effects of a topoisomerase I inhibitor on dioxin inducibility and high-level expression of the cytochrome P450IA1 gene.
K Gradin, R Toftgård and A Berghard

Molecular Pharmacology October 1995, 48 (4) 610-615;
You have access
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
R Alvarez, C Sette, D Yang, R M Eglen, R Wilhelm, E R Shelton and M Conti

Molecular Pharmacology October 1995, 48 (4) 616-622;
You have access
Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake.
M Popoli, C Vocaturo, J Perez, E Smeraldi and G Racagni

Molecular Pharmacology October 1995, 48 (4) 623-629;
You have access
Developmental and endocrine regulation of P450 isoforms in rat breast.
H Hellmold, J G Lamb, A Wyss, J A Gustafsson and M Warner

Molecular Pharmacology October 1995, 48 (4) 630-638;
You have access
Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.
P J Ciaccio, H Shen, A K Jaiswal, M H Lyttle and K D Tew

Molecular Pharmacology October 1995, 48 (4) 639-647;
You have access
Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter.
M A Desai, J P Burnett, N G Mayne and D D Schoepp

Molecular Pharmacology October 1995, 48 (4) 648-657;
You have access
Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
M Gupta, M Abdel-Megeed, Y Hoki, G Kohlhagen, K Paull and Y Pommier

Molecular Pharmacology October 1995, 48 (4) 658-665;
You have access
Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies.
K H Huh, T M Delorey, S Endo and R W Olsen

Molecular Pharmacology October 1995, 48 (4) 666-675;
You have access
Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
Z Pei, T P Calmels, C E Creutz and S M Sebti

Molecular Pharmacology October 1995, 48 (4) 676-681;
You have access
A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
U G Bhat, M A Winter, H L Pearce and W T Beck

Molecular Pharmacology October 1995, 48 (4) 682-689;
You have access
Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
N Yabaluri and F Medzihradsky

Molecular Pharmacology October 1995, 48 (4) 690-695;
You have access
Competition between positive and negative allosteric effectors on muscarinic receptors.
J Proska and S Tucek

Molecular Pharmacology October 1995, 48 (4) 696-702;
You have access
Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
B Lanier, R Raddatz, V Bakthavachalam, I Coupry, J L Neumeyer and S M Lanier

Molecular Pharmacology October 1995, 48 (4) 703-710;
You have access
Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor.
F Z Chung, L H Wu, Y Tian, M A Vartanian, H Lee, J Bikker, C Humblet, M C Pritchard, J Raphy and N Suman-Chauhan

Molecular Pharmacology October 1995, 48 (4) 711-716;
You have access
Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
A L Buller, H C Larson, R A Morrisett and D T Monaghan

Molecular Pharmacology October 1995, 48 (4) 717-723;
You have access
Structural requirements of analogues of polyamines for migration and growth of IEC-6 cells.
S A McCormack, B J Zimmerman, M Israel, P Blanner and L R Johnson

Molecular Pharmacology October 1995, 48 (4) 724-729;
You have access
D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
Z H Qin, L W Zhou, S P Zhang, Y Wang and B Weiss

Molecular Pharmacology October 1995, 48 (4) 730-737;
You have access
Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
C Chavany, Y Connell and L Neckers

Molecular Pharmacology October 1995, 48 (4) 738-746;
You have access
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
P M Seldon, P J Barnes, K Meja and M A Giembycz

Molecular Pharmacology October 1995, 48 (4) 747-757;
You have access
Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
G Chen, J E Wright and A Rosowsky

Molecular Pharmacology October 1995, 48 (4) 758-765;
You have access
Lysophosphatidic acid regulation of cyclic AMP accumulation in cultured human airway smooth muscle cells.
M Nogami, S M Whittle, D J Romberger, S I Rennard and M L Toews

Molecular Pharmacology October 1995, 48 (4) 766-773;
You have access
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
V Gerzanich, X Peng, F Wang, G Wells, R Anand, S Fletcher and J Lindstrom

Molecular Pharmacology October 1995, 48 (4) 774-782;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals